Sales and Marketing

Showing 15 posts of 11526 posts found.

Battle for Alzheimer’s drugs finally over

October 8, 2010 Sales and Marketing Alzheimer's, Aricept, NICE

NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …
Jonathan_Claire

Trio of appointments at 4Sight

October 7, 2010 Sales and Marketing 4Sight, appointment, sales and marketing

Bracknell, UK-based Commercial services company 4Sight has made three high-level appointments. Jonathan Hartless (pictured) joins as operations director from an …
GSK's Dr Pim Kon

Avandia should still be on the market, says GSK

October 7, 2010 Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline believes European regulators were wrong to withdraw its diabetes drug Avandia from the market, but will not challenge their …

NICE announces change of heart on Alzheimer’s

October 7, 2010 Sales and Marketing Alzheimer's, Aricept, Ebixa, Exelon, NICE, Reminyl

NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …

Pfizer ponders sale of Capsugel

October 7, 2010 Sales and Marketing Capsugel, Pfizer

Pfizer is reviewing options for its drug delivery systems business Capsugel, including a possible sale of the unit. Pfizer has …
GSK’s Seretide/Advair

New COPD and asthma treatments jostle for market space

October 6, 2010 Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma

Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …

Uncertainty over new cancer fund

October 6, 2010 Sales and Marketing Cancer, NHS, government

The UK government has launched its £50 million interim fund to give greater access to new cancer medicines. The new …

New Commercial Realities – Part 4 Key implications of this changing industry landscape for pharmaceutical commercial operations – governance

October 5, 2010 Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

GSK takes stake in biotech spin-out

October 5, 2010 Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding

GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …

Svend Andersen to lead Hospira in Europe

October 5, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing

US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …

Sanofi makes hostile offer for Genzyme

October 4, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …

Managing the Franchise

October 4, 2010 Sales and Marketing branding, marketing, product portfolio

Commercial managers who are responsible for a number of brands face a constant dilemma in choosing where across the franchise …

GSK drops herpes vaccine

October 4, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health

Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …

David Gallagher to head up IPHA

October 4, 2010 Sales and Marketing IPHA, appointment, sales and marketing

Pfizer Healthcare Ireland’s managing director David Gallagher has been elected president of the Irish Pharmaceutical Healthcare Association (IPHA). David has …
The Gateway to Local Adoption Series

Latest content